Skip to main content
. Author manuscript; available in PMC: 2006 Aug 28.
Published in final edited form as: J Pharm Pharmacol. 2006 May;58(5):591–598. doi: 10.1211/jpp.58.5.0003

Figure 3.

Figure 3

Anti-factor Xa activity-time profiles of ardeparin in rats after oral administration of formulations. Data are shown as the mean concentration, and error bars represent the s.d., n = 4–6.